Basic Information
| RNALocate ID: | RLID:11001275 |
| RNA Symbol: | hsa-miR-198 |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-198 |
| RNA ID: | miRBase:MIMAT0000228 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21505438 |
| Tissue/Cell Line: | B cell line (Raji)|Jurkat-derived T cell line (J77cl20) |
| Method: | Microarray |
| Description: | Microarray analysis of exosomal miRNAs verses the miRNAs of their respective donor cells. Data are collected from Supplementary Data 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001559 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001560 | Mitochondrion | Liver tissue | 27396686 |
| RLID:01001561 | Mitochondrion | Liver cells | 19106625 |
| RLID:01001562 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11001274 | Exosome | Primary T lymphocytes | 24356509 |
| RLID:11001276 | Exosome | Brain tissue | 23382797 |
| RLID:11001277 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001278 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
| RLID:11001279 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11001163 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine | |
| RLID-D:11003912 | Microvesicle | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-198 | Splenic marginal zone lymphoma | MNDR-E-MI-24465 |
| MNDR | hsa-miR-198 | Oral squamous cell carcinoma | MNDR-E-MI-24466 |
| MNDR | hsa-miR-198 | Lymphoma | MNDR-E-MI-24467 |
| MNDR | hsa-miR-198 | Lymphoma non-hodgkin | MNDR-E-MI-24468 |
| MNDR | hsa-miR-198 | Estrogen-receptor positive breast cancer | MNDR-E-MI-24469 |
| MNDR | hsa-miR-198 | Estrogen-receptor negative breast cancer | MNDR-E-MI-24470 |
| MNDR | hsa-miR-198 | Progesterone-receptor positive breast cancer | MNDR-E-MI-24471 |
| MNDR | hsa-miR-198 | Progesterone-receptor negative breast cancer | MNDR-E-MI-24472 |
| MNDR | hsa-miR-198 | Her2-receptor positive breast cancer | MNDR-E-MI-24473 |
| MNDR | hsa-miR-198 | Breast cancer luminal | MNDR-E-MI-24474 |
| MNDR | hsa-miR-198 | Anencephaly | MNDR-E-MI-24475 |
| MNDR | hsa-miR-198 | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-24476 |
| MNDR | hsa-mir-198 | Lupus nephritis | MNDR-E-MI-24477 |
| MNDR | hsa-miR-198 | B cell acute lymphoblastic leukemia | MNDR-E-MI-24478 |
| MNDR | hsa-mir-198 | Melanoma and neural system tumor syndrome | MNDR-E-MI-24479 |
| MNDR | hsa-mir-198 | Prostate cancer | MNDR-E-MI-24480 |
| MNDR | hsa-miR-198 | Prostate cancer | MNDR-E-MI-24481 |
| MNDR | hsa-miR-198 | Gastric cancer | MNDR-E-MI-24482 |
| MNDR | hsa-miR-198 | Gastric lymphoma | MNDR-E-MI-24483 |
| MNDR | hsa-mir-198 | Pre-eclampsia | MNDR-E-MI-24484 |
| MNDR | hsa-miR-198 | Alzheimer disease | MNDR-E-MI-24485 |
| MNDR | hsa-mir-198 | Sickle cell diseases | MNDR-E-MI-24486 |
| MNDR | hsa-miR-198 | Intracranial aneurysm | MNDR-E-MI-24487 |
| MNDR | hsa-mir-198 | Carcinoma esophageal | MNDR-E-MI-24488 |
| MNDR | hsa-miR-198 | Dysautonomia familial | MNDR-E-MI-24489 |
| MNDR | hsa-miR-198 | Leukemia | MNDR-E-MI-24490 |
| MNDR | hsa-miR-198 | Huntington disease | MNDR-E-MI-24491 |
| MNDR | hsa-miR-198 | Brain cancer | MNDR-E-MI-24492 |
| MNDR | hsa-miR-198 | Lung cancer | MNDR-E-MI-24493 |
| MNDR | hsa-mir-198 | Lung cancer | MNDR-E-MI-24494 |
| MNDR | hsa-miR-198 | Parkinson disease | MNDR-E-MI-24495 |
| MNDR | hsa-miR-198 | Basal-like breast cancer | MNDR-E-MI-24496 |
| MNDR | hsa-mir-198 | Breast cancer | MNDR-E-MI-24497 |
| MNDR | hsa-mir-198 | Cancer | MNDR-E-MI-24498 |
| MNDR | hsa-mir-198 | Pancreatic cancer | MNDR-E-MI-24499 |
| MNDR | hsa-miR-198 | Pancreatic cancer | MNDR-E-MI-24500 |
| MNDR | hsa-miR-198 | Melanoma | MNDR-E-MI-24501 |
| MNDR | hsa-miR-198 | Nephroblastoma | MNDR-E-MI-24502 |
| MNDR | hsa-miR-198 | Colon cancer | MNDR-E-MI-24503 |
| MNDR | hsa-miR-198 | Ischemic attack transient | MNDR-E-MI-24504 |
| MNDR | hsa-miR-198 | Familial ovarian cancer | MNDR-E-MI-24505 |
| MNDR | hsa-mir-198 | Ovarian cancer | MNDR-E-MI-24506 |
| MNDR | hsa-miR-198 | Kidney cancer | MNDR-E-MI-24507 |
| MNDR | hsa-mir-198 | Glioblastoma | MNDR-E-MI-24508 |
| MNDR | hsa-miR-198 | Glioma | MNDR-E-MI-24509 |
| MNDR | hsa-mir-198 | Glioma | MNDR-E-MI-24510 |
| MNDR | hsa-miR-198 | Amyotrophic lateral sclerosis | MNDR-E-MI-24511 |
| MNDR | hsa-miR-198 | Osteosarcoma | MNDR-E-MI-24512 |
| MNDR | hsa-mir-198 | Osteosarcoma | MNDR-E-MI-24513 |
| MNDR | hsa-mir-198 | Coronary artery disease | MNDR-E-MI-24514 |
| MNDR | hsa-mir-198 | Pancreatic ductal adenocarcinoma | MNDR-E-MI-24515 |
| MNDR | hsa-miR-198 | Hepatocellular cancer | MNDR-E-MI-24516 |
| MNDR | hsa-miR-198 | Uterine cancer | MNDR-E-MI-24517 |
| MNDR | hsa-miR-198 | Lung squamous cell carcinoma | MNDR-E-MI-24518 |
| MNDR | hsa-miR-198 | Lung adenocarcinoma | MNDR-E-MI-24519 |
| MNDR | hsa-mir-198 | Pancreatic adenocarcinoma | MNDR-E-MI-24520 |
| MNDR | hsa-miR-198 | Cholangiocarcinoma | MNDR-E-MI-24521 |
| MNDR | hsa-miR-198 | Esophageal cancer | MNDR-E-MI-24522 |
| MNDR | hsa-miR-198 | Lung small cell carcinoma | MNDR-E-MI-24523 |
| MNDR | hsa-mir-198 | Schizophrenia | MNDR-E-MI-24524 |
| MNDR | hsa-mir-198 | Head and neck squamous cell carcinoma | MNDR-E-MI-24525 |
| MNDR | hsa-miR-198 | T acute lymphoblastic leukemia | MNDR-E-MI-24526 |
| MNDR | hsa-miR-198 | Acute t cell leukemia | MNDR-E-MI-24527 |
| MNDR | hsa-mir-198 | Acquired immunodeficiency syndrome | MNDR-E-MI-24528 |
| MNDR | hsa-miR-198 | Progressive supranuclear palsy | MNDR-E-MI-24529 |
| MNDR | hsa-mir-198 | Carcinoma hepatocellular | MNDR-E-MI-24530 |
| MNDR | hsa-miR-198 | Hepatocellular carcinoma | MNDR-E-MI-24531 |
| MNDR | hsa-miR-198 | Familiar ovarian carcinoma | MNDR-E-MI-24532 |
| MNDR | hsa-miR-198 | B-cell lymphoma | MNDR-E-MI-24533 |
| MNDR | hsa-miR-198 | T-cell leukemia | MNDR-E-MI-24534 |
| MNDR | hsa-miR-198 | Malignant pleural mesothelioma | MNDR-E-MI-24535 |
| MNDR | hsa-miR-198 | Retinoblastoma | MNDR-E-MI-24536 |
| MNDR | hsa-mir-198 | Gastrointestinal system disease | MNDR-E-MI-24537 |
| MNDR | hsa-mir-198 | Hodgkin lymphoma | MNDR-E-MI-24538 |
| MNDR | hsa-miR-198 | Hodgkin lymphoma | MNDR-E-MI-24539 |
| MNDR | hsa-miR-198 | Burkitt lymphoma | MNDR-E-MI-24540 |
| MNDR | hsa-miR-198 | Tonsil cancer | MNDR-E-MI-24541 |
| MNDR | hsa-mir-198 | Systemic lupus erythematosus | MNDR-E-MI-24542 |
| MNDR | hsa-mir-198 | Leukemia acute myeloid | MNDR-E-MI-24543 |
| MNDR | hsa-mir-198 | Colorectal cancer | MNDR-E-MI-24544 |
| MNDR | hsa-miR-198 | Colorectal cancer | MNDR-E-MI-24545 |
| MNDR | hsa-miR-198 | Nasopharynx carcinoma | MNDR-E-MI-24546 |
| MNDR | hsa-mir-198 | Multiple myeloma | MNDR-E-MI-24547 |
| MNDR | hsa-miR-198 | Multiple myeloma | MNDR-E-MI-24548 |
| MNDR | hsa-miR-198 | Acute lymphocytic leukemia | MNDR-E-MI-24549 |
| MNDR | hsa-mir-198 | Lupus vulgaris | MNDR-E-MI-24550 |
| MNDR | hsa-miR-198 | Nasopharyngeal cancer | MNDR-E-MI-24551 |
| MNDR | hsa-mir-198 | Prostatic neoplasms | MNDR-E-MI-24552 |
| MNDR | hsa-miR-198 | Pancreatitis chronic | MNDR-E-MI-24553 |
| MNDR | hsa-miR-198 | Stroke lacunar | MNDR-E-MI-24554 |
| MNDR | hsa-miR-198 | Breast cancer her3+ negative | MNDR-E-MI-24555 |
| MNDR | hsa-mir-198 | Systemic lupus erythematosus susceptibility | MNDR-E-MI-24556 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | BIRC7 | Homo sapiens | RR00225394 |
TOP